- Home
- SNN vs CELH Comparison
SNN vs CELH Comparison
Compare SNN & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNN
- CELH
- Stock Information
- Founded
- SNN 1856
- CELH 2004
- Country
- SNN United Kingdom
- CELH United States
- Employees
- SNN N/A
- CELH N/A
- Industry
- SNN Industrial Specialties
- CELH Beverages (Production/Distribution)
- Sector
- SNN Health Care
- CELH Consumer Staples
- Exchange
- SNN Nasdaq
- CELH Nasdaq
- Market Cap
- SNN 13.2B
- CELH 12.0B
- IPO Year
- SNN 1999
- CELH N/A
- Fundamental
- Price
- SNN $30.16
- CELH $44.43
- Analyst Decision
- SNN Hold
- CELH Strong Buy
- Analyst Count
- SNN 3
- CELH 16
- Target Price
- SNN $27.50
- CELH $47.31
- AVG Volume (30 Days)
- SNN 1.2M
- CELH 5.4M
- Earning Date
- SNN 07-31-2025
- CELH 08-05-2025
- Dividend Yield
- SNN 2.39%
- CELH N/A
- EPS Growth
- SNN 56.15
- CELH N/A
- EPS
- SNN 0.47
- CELH 0.32
- Revenue
- SNN $5,810,000,000.00
- CELH $1,329,198,000.00
- Revenue This Year
- SNN $6.87
- CELH $61.03
- Revenue Next Year
- SNN $5.19
- CELH $25.65
- P/E Ratio
- SNN $31.89
- CELH $136.62
- Revenue Growth
- SNN 4.70
- CELH N/A
- 52 Week Low
- SNN $23.69
- CELH $21.10
- 52 Week High
- SNN $31.72
- CELH $52.10
- Technical
- Relative Strength Index (RSI)
- SNN 53.71
- CELH 53.01
- Support Level
- SNN $29.27
- CELH $43.05
- Resistance Level
- SNN $31.43
- CELH $46.20
- Average True Range (ATR)
- SNN 0.43
- CELH 1.38
- MACD
- SNN -0.09
- CELH -0.45
- Stochastic Oscillator
- SNN 41.20
- CELH 29.74
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and the recently acquired portfolio of Alani Nu energy drinks and snacks. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.